Q Biomed (QBIO) Stock Price, News & Analysis

Company Overview

Q Biomed Inc. is a biotechnology and healthcare company focused on identifying, acquiring, developing and commercializing biomedical products and technologies. Its business model has included licensing and partnering with research institutions, biotechnology companies and other healthcare organizations to advance products toward the market.

The company has pursued opportunities across areas such as therapeutics, diagnostics and medical devices, with an emphasis on products that may address unmet medical needs. Its activities have included supporting the development, regulatory advancement and commercialization of acquired or licensed technologies rather than operating solely as a traditional drug-discovery company.

Q Biomed has been publicly traded in the United States under the symbol QBIO. Publicly available information about its current product portfolio, geographic operations and leadership is limited, and the company’s programs and corporate structure may change as it evaluates new biomedical opportunities.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Last Earnings: 7/14/2021
• Today: 10/14/2026
• Fiscal Year End: 11/30/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:QBIO
• Previous Symbol: NASDAQ:QBIO
• CIK: 1596062
• Web: www.qbiomed.com
• Phone: (646) 889-2226
• Fax: N/A
• Employees: 3
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A